
Entia Biosciences, Inc. 
 Aktie · US29384E1047    (OTC)
                    Kein Kurs
                
                        Schlusskurs OTC 03.11.2025:
                        0,0001 USD
                    
 
            03.11.2025 21:00
        
Aktuelle Kurse von Entia Biosciences, Inc.
| Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | 
|---|---|---|---|---|---|
UTC  | 
                                ERGO
                              | 
                                USD
                              | 
                                03.11.2025 21:00
                              | 
                                0,0001 USD
                              | 0,00 USD   | 
        Firmenprofil zu Entia Biosciences, Inc. Aktie
    
 Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
 Unternehmensdaten
Name Entia Biosciences, Inc.
 Firma Entia Biosciences, Inc.
  Website 
                            https://www.entiabio.com
                        
 Heimatbörse 
                        UTC
                    
  ISIN US29384E1047
 Wertpapierart Aktie
     Sektor Healthcare
 Branche Biotechnology
 CEO Timothy A. Timmins
  Land Vereinigte Staaten von Amerika
 Währung USD
 Mitarbeiter 0,0 T
 Adresse 13565 SW Tualatin-Sherwood Road, 97140 Sherwood
 IPO Datum 2008-01-18
Ticker Symbole
| Name | Symbol | 
|---|---|
| Over The Counter | ERGO | 
            Weitere Aktien
            
 
                Investoren, die Entia Biosciences, Inc. halten, haben auch folgende Aktien im Depot:
            
            Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
 Vom Wertpapier-Depot bis zum Crypto-Kauf.
            
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
 Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.


